CMS GLP-1 obesity coverage pilot raises questions
news.google.com
A new pilot testing coverage for GLP-1 obesity drugs under Medicare has sparked debate over costs, access, and the agency’s understanding of long‑term effects.
Continue reading at news.google.com →
Related Reading
- MGB Health Plan removes Dana-Farber Cancer Institute from Medicare Advantage network · CBS News · 27m ago
- What conditions caused a Delmar assisted living facility to close? · news10.com · 33m ago
- Nursing Home Jobs Nearly Flat in August as Healthcare Hiring Slows · Skilled Nursing News · 54m ago
- As Special Needs Plans Surge, CMS Weighs Consolidating Plan Types Against Specialized Care in Nursing Homes · Skilled Nursing News · 54m ago
- MGB removes Dana-Farber Cancer Institute from Medicare Advantage network · CBS News · 1h ago
